• Tel. 900 101 549
  • +34 93 546 01 35
  • Facebook IOR
  • Twitter IOR
  • LinkedIn IOR
  • Hospital Universitari Dexeus
  • Centro Médico Teknon
  • Hospital Universitari General de Cataluña
  • Hospital Universitari Sagrat Cor

SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

01/05/2012

Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications

AUTHORS Clara Mayo, Jordi Bertran-Alamillo, Miguel Ángel Molina-Vila, Ana Giménez-Capitán, Carlota Costa & Rafael Rosell

PUBLICATION Pharmacogenomics

READ ARTICLE

01/03/2012

Erlotinib versus chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

AUTHORS Dr Rafael Rosell et al. on behalf of the Spanish Lung Cancer Group in collaboration with the Groupe Français de Pneumo-Cancérologie and the Associazione Italiana Oncologia Toracica

PUBLICATION The Lancet Oncology

READ ARTICLE

24/03/2011

FAS and NF-kB signalling modulate dependence of lung cancers on mutant EGFR

AUTHORS Trever G. Bivona, Haley Hieronymus, Joel Parker, Kenneth Chang, Miquel Taron, Rafael Rosell, Philicia Moonsamy, Kimberly Dahlman, Vincent A. Miller, Carlota Costa, Gregory Hannon & Charles L. Sawyers

PUBLICATION Nature

READ ARTICLE

07/03/2011

Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study

AUTHORS Schöffski P, Taron M, Jimeno J, Grosso F, Sanfilipio R, Casali PG, Le Cesne A, Jones RL, Blay JY, Poveda A, Maki RG, Nieto A, Tercero JC, Rosell R

PUBLICATION European Journal of Cancer

READ ARTICLE

01/03/2011

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced non-small cell lung cancer

AUTHORS Rosell, Rafael; Viteri, Santiago; Molina, Miguel Angel; Benlloch, Susana; Taron, Miquel

PUBLICATION Current Opinion in Oncology

READ ARTICLE